Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system.

Wattanapanitch M, Damkham N, Potirat P, Trakarnsanga K, Janan M, U-Pratya Y, Kheolamai P, Klincumhom N, Issaragrisil S.

Stem Cell Res Ther. 2018 Feb 26;9(1):46. doi: 10.1186/s13287-018-0779-3.

2.

Inhibition of O-GlcNAcase Sensitizes Apoptosis and Reverses Bortezomib Resistance in Mantle Cell Lymphoma through Modification of Truncated Bid.

Luanpitpong S, Chanthra N, Janan M, Poohadsuan J, Samart P, U-Pratya Y, Rojanasakul Y, Issaragrisil S.

Mol Cancer Ther. 2018 Feb;17(2):484-496. doi: 10.1158/1535-7163.MCT-17-0390. Epub 2017 Nov 22.

PMID:
29167312
3.

Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients.

Janan M, Proungvitaya S, Limpaiboon T, Proungvitaya T, Roytrakul S, Wongkham C, Jearanaikoon P, Chur-in S, Wongkham S.

Asian Pac J Cancer Prev. 2012;13 Suppl:107-14.

Supplemental Content

Support Center